IDEXX Laboratories shareholders approved amendments declassifying the Board over three years and granting 25% shareholders the right to call special meetings at the 2026 Annual Meeting.
Key takeaways
Shareholders elected Daniel M. Junius, Lawrence D. Kingsley, and Sophie V. Vandebroek as Class II directors for terms expiring in 2029.
Approved Certificate of Incorporation amendments to declassify Board, with annual elections for all directors starting 2029.
Approved right for shareholders owning 25% of capital stock continuously for one year to request special meetings.
Ratified PricewaterhouseCoopers LLP as independent registered accounting firm for current fiscal year.
Advisory approval of named executive officer compensation.
Rejected shareholder proposal for special meeting rights (28M for vs 40M against).